5432752026-01-012026-03-315432752026-03-315432752025-03-315432752025-04-012026-03-315432752026-01-012026-03-31in-capmkt:OtherExpenses1Member5432752025-04-012026-03-31in-capmkt:OtherExpenses1Member5432752026-03-31OtherNoncurrentFinancialAssetsDomain15432752026-03-31OtherNoncurrentAssetsDomain15432752026-03-31OtherCurrentFinancialAssetsDomain15432752026-03-31OtherCurrentAssetsDomain15432752026-03-31OtherNoncurrentFinancialLiabilitiesDomain15432752026-03-31OtherNoncurrentFinancialLiabilitiesDomain25432752026-03-31OtherCurrentFinancialLiabilitiesDomain15432752026-03-31OtherCurrentFinancialLiabilitiesDomain25432752026-03-31OtherCurrentLiabilitiesDomain15432752026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432752026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25432752025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15432752025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25432752026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15432752026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25432752025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15432752025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25432752026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares543275ANURASNOTLISTEDINE930P01018ANUPAM RASAYAN INDIA LIMITEDMain BoardEquity2025-04-012026-03-312026-05-232026-05-20INRMillionsQuarterlyFourth quarterSingle segmentManufacturing of Industrial Chemicals2026-05-2312:45:002026-05-2316:55:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated635783000033690000639152000038575800000-542630000308200000419130000426770000136179000058308400005606800000560680000127550000-126830000720000055996000000005599600001153500006753100004265000001334600005424400001328600001138480000103.753.75003.753.751.The above Consolidated Financial results for the quarter and year ended March 31 2026 have been prepared by the Company in accordance with Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015 as amended and were reviewed by the Audit Committee of the Board and thereafter were approved and taken on record by the Board of Directors in their meeting held on May 23 2026. <BR> 2.Based on the management approach as defined in Ind AS 108 Operating Segments the Chief Operating Decision Maker CODM evaluates the companys performance and allocates resources based on an analysis of various performance indicators of business segments in which the company operates. <BR> The Company is primarily engaged in the business of custom synthesis and manufacturing of specialty chemicals which the management and CODM recognise as the sole business segment. Hence disclosure of segment wise information is not required and accordingly not provided. <BR> 3.The company consummated acquisition of 100 percent equity stake in Jayhawk Fine Chemicals Corporation Jayhawk part of the CABB group a U.S. based specialty chemical company effectively from February 27 2026 for a purchase consideration of US dollar150 million through its wholly owned subsidiary Doriath S.a r.l. Detail disclosure in this regard has been made via press release dated February 27 2026 submitted with the stock exchanges vide Document No. ARILSLDSTX20260227093. <BR> 4.The Group has recognised the goodwill of INR 5402.56 million related to the acquisition of JayHawk through its wholly owned subsidiary Doriath S.a.r.l on a provisional basis as per Ind AS 103 Business Combinations since the valuation of certain identifiable intangible assets property plant and equipment and related deferred taxes is under process with the valuers. The Group expects to finalize the purchase price allocation within the measurement period permitted under Ind AS 103. <BR> 5.The Board of Directors have recommended final dividend of INR 1.5 per Equity Share at 15 percent per Equity Share of face value of INR 10 each for the financial year 2025 to 2026. <BR> 6.Deferred tax assets and liabilities have been recomputed by the Parent company based on the enactment of Finance Bill 2026. The resulting impact of the remeasurement of deferred tax balances has been recognized in the Statement of Profit and Loss for the year. <BR> 7.The Company has investment in the following Subsidiary companies including step down subsidiaries and into an Associate Company of Wholly owned subsidiary WOS through a WOS as on March 31 2026 and accordingly Consolidated Financial Results for the Quarter and year ended on March 31 2026 include following entities <BR> Name of the Company Nature of relationship <BR> a Jainam Intermediates Private Limited Whollyowned subsidiary <BR> b Tanfac Industries Limited Subsidiary Company over which the Company exercises effective control <BR> c ARIL Transmodal Logistic Private Limited Whollyowned subsidiary <BR> d ARIL Fluorospeciality Private Limited Whollyowned subsidiary <BR> e Anupam Japan GK Whollyowned subsidiary <BR> f Anupam Europe AG Whollyowned subsidiary <BR> g Anupam USA LLC Whollyowned subsidiary <BR> h Anupam General Trading FZE Whollyowned subsidiary <BR> i Tangent Science Private Limited An associate Company of wholly owned subsidiary of the Company <BR> j Doriath S.a.r.l Whollyowned subsidiary <BR> j1 Monitchem Kansas S.a.r.l Step Down Subsidiary Level I of Whollyowned subsidiary <BR> j2 Kansas Hold Co. Step Down Subsidiary Level II of Whollyowned subsidiary <BR> j3 Kansas Hold Co. 1 Step Down Subsidiary Level III of Whollyowned subsidiary <BR> j4 Jayhawk Fine Chemicals Corporation Step Down Subsidiary Level IV of Whollyowned subsidiary <BR> 8.The figures for the quarter ended March 31 2026 and March 31 2025 are the balancing figures between audited figures in respect of the full financial year and the published year to date figures up to Nine months of the relevant financial year which were subjected to limited review. <BR> 9.The figures of the previous period have been re grouped rearranged and or recasted wherever considered necessary. 2025-04-012026-03-31AuditedConsolidated2365455000018174000023836290000144200700000-118751000086575000014871200001399000000430782000021292250000254404000002544040000520630000-1985800003220500000222199000000002221990000714600002293450000170121000052078000017724700005209800001138480000103187990000015.0915.090015.0915.09Other Expenses1361790000Other Expenses430782000029800580000114429000066346100006927900001530000014629000013673100001528900000304980000042850970000177475200001699100009593850000378069000015556000016760000483100001376508000064850000569762000037275070000801260400001457600000318799000003333750000012962100000462996000005108460000940290000604875000014660000160864000076720500001303809000051126000089440300009455290000216532000024658700000118025000025618000059260000261543900003382644000080126040000Other non-current financial assets1367310000Other non-current assets3049800000Other current financial assets48310000Other current assets5697620000Lease Liability485700000Other Financial Liabilities454590000Lease Liability42620000Other Financial Liabilities2122700000Other current liabilities11802500001508140000-1557520000-3311980000026555000000757830000021387000000001399000000035500000006445000004500000280000-50000000-1729000008440000012496500003793690000000450430000033432600000000000011520000555156000022192600004211110000000000000002578000000025000045000000-649460000-8202380000002775470000000004707210000028750000015200000013620300000528150000620930000013501800000135018000024309300003781110000Gain/(loss) on remeasurements of the defined benefits plan8750000Income tax (expense)/income on remeasurements of the defined benefits plan-33700005380000Gain/(loss) on remeasurements of the defined benefits plan-7860000Income tax (expense)/income on remeasurements of the defined benefits plan2560000-530000000Effective portion of gain/(loss) on hedging instruments in a cash flow hedge109970000Income tax (expense)/income on effective portion of gain/(loss) on hedging instruments in a cash flow hedge0109970000Effective portion of gain/(loss) on hedging instruments in a cash flow hedge76760000Income tax (expense)/income on effective portion of gain/(loss) on hedging instruments in a cash flow hedge0767600000011535000071460000AuditedtrueM/s. Natvarlal Vepari & Co.true2027-05-31